DIA 2017 Annual Meeting

Agenda

Day 1 Jun 19, 2017

11:00 AM — 12:15 PM

Breaking Down the Wall for FDA to Leverage Real World Data

Day 2 Jun 20, 2017

10:30 AM — 11:45 AM

Outcomes Standardization: An Imperative to Value Assessments

2:00 PM — 3:00 PM

Comparative Effectiveness: State of the Art and Stakeholder Perspectives

4:00 PM — 5:15 PM

Breaking Down the Wall for Global Regulators to Leverage Real World Data

4:00 PM — 5:15 PM

Value and Access for Special Populations: From Access Restriction to Drug Mortgages

Day 3 Jun 21, 2017

10:30 AM — 11:45 AM

Real-World Data to Real World Evidence for Assessing Efficacy and Effectiveness

2:00 PM — 3:00 PM

Biosimilars and Generics: Access Versus Innovation

2:00 PM — 3:15 PM

Value-Based Conversations with Payers: Issues, Opportunities, and Barriers

4:00 PM — 5:15 PM

The Increasing Role for Big Data for Late Phase Drug and Postapproval Purposes

Have an account?